Lapatinib Plus Trametinib in KRAS Mutant NSCLC
Clinical trial NCT02230553 · COMPLETED
Trial details
- NCT number
- NCT02230553
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-07
- Primary completion
- 2019-07-29
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.